135 related articles for article (PubMed ID: 28338993)
1. Dihydrocelastrol inhibits multiple myeloma cell proliferation and promotes apoptosis through ERK1/2 and IL-6/STAT3 pathways in vitro and in vivo.
Hu L; Wu H; Li B; Song D; Yang G; Chen G; Xie B; Xu Z; Zhang Y; Yu D; Hou J; Xiao W; Sun X; Chang G; Zhang Y; Gao L; Dai B; Tao Y; Shi J; Zhu W
Acta Biochim Biophys Sin (Shanghai); 2017 May; 49(5):420-427. PubMed ID: 28338993
[TBL] [Abstract][Full Text] [Related]
2. Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation.
Jin S; Li B; Zhang B; Gao X; Jia X; Xu L; Chang S; Hu K; Wang G; Xu Z; Zhang T; Song D; Yang G; Wu X; Zhu H; Huang C; Lu Y; Shi J; Zhu W; Chen G
Acta Biochim Biophys Sin (Shanghai); 2023 Dec; 55(12):1884-1891. PubMed ID: 38009004
[TBL] [Abstract][Full Text] [Related]
3. Dihydrocelastrol exerts potent antitumor activity in mantle cell lymphoma cells via dual inhibition of mTORC1 and mTORC2.
Xie Y; Li B; Bu W; Gao L; Zhang Y; Lan X; Hou J; Xu Z; Chang S; Yu D; Xie B; Wang Y; Wang H; Zhang Y; Wu X; Zhu W; Shi J
Int J Oncol; 2018 Aug; 53(2):823-834. PubMed ID: 29901111
[TBL] [Abstract][Full Text] [Related]
4. Platycodin D inhibits proliferation, migration and induces chemosensitization through inactivation of the NF-κB and JAK2/STAT3 pathways in multiple myeloma cells.
Wu D; Zhang W; Chen Y; Ma H; Wang M
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1194-1200. PubMed ID: 31347196
[TBL] [Abstract][Full Text] [Related]
5. The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival.
Scuto A; Krejci P; Popplewell L; Wu J; Wang Y; Kujawski M; Kowolik C; Xin H; Chen L; Wang Y; Kretzner L; Yu H; Wilcox WR; Yen Y; Forman S; Jove R
Leukemia; 2011 Mar; 25(3):538-50. PubMed ID: 21164517
[TBL] [Abstract][Full Text] [Related]
6. Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivo.
Burger R; Le Gouill S; Tai YT; Shringarpure R; Tassone P; Neri P; Podar K; Catley L; Hideshima T; Chauhan D; Caulder E; Neilan CL; Vaddi K; Li J; Gramatzki M; Fridman JS; Anderson KC
Mol Cancer Ther; 2009 Jan; 8(1):26-35. PubMed ID: 19139110
[TBL] [Abstract][Full Text] [Related]
7. Pterostilbene Inhibits Human Multiple Myeloma Cells via ERK1/2 and JNK Pathway In Vitro and In Vivo.
Xie B; Xu Z; Hu L; Chen G; Wei R; Yang G; Li B; Chang G; Sun X; Wu H; Zhang Y; Dai B; Tao Y; Shi J; Zhu W
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869675
[TBL] [Abstract][Full Text] [Related]
8. Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells.
Kannaiyan R; Hay HS; Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Chng WJ; Sethi G
Br J Pharmacol; 2011 Nov; 164(5):1506-21. PubMed ID: 21506956
[TBL] [Abstract][Full Text] [Related]
9. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways.
Zuo D; Zhou Z; Wang H; Zhang T; Zang J; Yin F; Sun W; Chen J; Duan L; Xu J; Wang Z; Wang C; Lin B; Fu Z; Liao Y; Li S; Sun M; Hua Y; Zheng L; Cai Z
J Cell Mol Med; 2017 Feb; 21(2):208-221. PubMed ID: 27624867
[TBL] [Abstract][Full Text] [Related]
10. The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cells.
Monaghan KA; Khong T; Burns CJ; Spencer A
Leukemia; 2011 Dec; 25(12):1891-9. PubMed ID: 21788946
[TBL] [Abstract][Full Text] [Related]
11. Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma.
Gao M; Li B; Sun X; Zhou Y; Wang Y; Tompkins VS; Xu Z; Indima N; Wang H; Xiao W; Gao L; Chen G; Wu H; Wu X; Kong Y; Xie B; Zhang Y; Chang G; Hu L; Yang G; Dai B; Tao Y; Zhu W; Shi J
Theranostics; 2017; 7(15):3690-3699. PubMed ID: 29109769
[TBL] [Abstract][Full Text] [Related]
12. A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells.
Lin L; Benson DM; DeAngelis S; Bakan CE; Li PK; Li C; Lin J
Int J Cancer; 2012 Mar; 130(6):1459-69. PubMed ID: 21520044
[TBL] [Abstract][Full Text] [Related]
13. Induction of cell cycle arrest and apoptosis by CPUC002 through stabilization of p53 and suppression of STAT3 signaling pathway in multiple myeloma.
Zhao Y; Bai D; Du J; Ren H; Zhang Z; Jiang C; Lu N
Cell Biol Toxicol; 2021 Feb; 37(1):97-111. PubMed ID: 33126266
[TBL] [Abstract][Full Text] [Related]
14. A novel aryl-guanidinium derivative, VP79s, targets the signal transducer and activator of transcription 3 signaling pathway, downregulates myeloid cell leukaemia-1 and exhibits preclinical activity against multiple myeloma.
Amet R; Previtali V; Mihigo HB; Sheridan E; Brophy S; Hante NK; Santos-Martinez MJ; Hayden PJ; Browne PV; Rozas I; McElligott AM; Zisterer DM
Life Sci; 2022 Feb; 290():120236. PubMed ID: 34953891
[TBL] [Abstract][Full Text] [Related]
15. Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma.
Lai Y; Guo S; Tang Q; Chang G; Zhang H; Li B; Feng Q; Hu K; Xu Z; Gao X; Zhang Q; Yi H; Song D; Zhang Y; Peng Y; Cai H; Zhu W; Shi J
Arch Biochem Biophys; 2024 Apr; 754():109929. PubMed ID: 38367794
[TBL] [Abstract][Full Text] [Related]
16. The farnesyltransferase inhibitor L744832 potentiates UCN-01-induced apoptosis in human multiple myeloma cells.
Pei XY; Dai Y; Rahmani M; Li W; Dent P; Grant S
Clin Cancer Res; 2005 Jun; 11(12):4589-600. PubMed ID: 15958645
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells.
Bhardwaj A; Sethi G; Vadhan-Raj S; Bueso-Ramos C; Takada Y; Gaur U; Nair AS; Shishodia S; Aggarwal BB
Blood; 2007 Mar; 109(6):2293-302. PubMed ID: 17164350
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane A2 Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase (MAPK)-mediated G2/M Progression Delay and Cell Apoptosis.
Liu Q; Tao B; Liu G; Chen G; Zhu Q; Yu Y; Yu Y; Xiong H
J Biol Chem; 2016 Feb; 291(9):4779-92. PubMed ID: 26724804
[TBL] [Abstract][Full Text] [Related]
19. Patrinia scabiosaefolia extract suppresses proliferation and promotes apoptosis by inhibiting the STAT3 pathway in human multiple myeloma cells.
Peng J; Chen Y; Lin J; Zhuang Q; Xu W; Hong Z; Sferra TJ
Mol Med Rep; 2011; 4(2):313-8. PubMed ID: 21468570
[TBL] [Abstract][Full Text] [Related]
20. DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway.
Sun X; Li B; Xie B; Xu Z; Chang G; Tao Y; Zhang Y; Chang S; Wang Y; Yu D; Xie Y; Li T; Wang H; Chen G; Hu L; Hou J; Zhang Y; Xiao W; Gao L; Shi J; Zhu W
Cell Death Dis; 2017 Oct; 8(10):e3111. PubMed ID: 29022919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
